 DUBLIN, Ireland and CHICAGO, Sept. 28, 2021 GLOBE NEWSWIRE -- Iterum Therapeutics plc Nasdaq: ITRM the Company, a clinical-stage pharmaceutical company focused on developing next generation oral and IV antibiotics to treat infections caused by multi-drug resistant pathogens in both community and hospital settings, today announced a data presentation at the Infectious Disease Society of America IDSA IDWeekTM 2021, taking place virtually from September 29 October 3, 2021. 